Reproductive history, hormone replacement, and incidence of venous thromboembolism: The longitudinal investigation of thromboembolism etiology

British Journal of Haematology

Volumn 149, Issue 4, 2010, Pages 606-612

  Ohira, Tetsuya ^a,b   Folsom, Aaron R ^a   Cushman, Mary ^c   White, Richard H ^d   Hannan, Peter J ^a   Rosamond, Wayne D ^e   Heckbert, Susan R ^f  

^a UNIVERSITY OF MINNESOTA   (United States)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e IL   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Epidemiology; Hormone therapy; Menopause; Risk factors; Venous thrombosis

Indexed keywords

ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; ARTICLE; ATHEROSCLEROSIS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MENOPAUSE; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCTIVE HISTORY; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

AGE FACTORS; AGED; EPIDEMIOLOGIC METHODS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PARITY; PREGNANCY; REPRODUCTIVE HISTORY; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 77951694703     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08128.x     Document Type: Article

References (22)

1. Canonico, M., Plu-Bureau, G., Lowe, G.D. Scarabin, P.Y. (2008) Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ, 336, 1227 1231. (Pubitemid 351809317)
2. Cushman, M., Cornell, E.S., Howard, P.R., Bovill, E.G. Tracy, R.P. (1995) Laboratory methods and quality assurance in the Cardiovascular Health Study. Clinical Chemistry, 41, 264 270.
3. Cushman, M., Psaty, B.M., Meilahn, E.N., Dobs, A.S. Kuller, L.H. (2001) Post-menopausal hormone therapy and concentrations of protein C and antithrombin in elderly women. British Journal of Haematology, 114, 162 168. (Pubitemid 32702650)
4. Cushman, M., Kuller, L.H., Prentice, R., Rodabough, R.J., Psaty, B.M., Stafford, R.S., Sidney, S. Rosendaal, F.R. (2004a) Estrogen plus progestin and risk of venous thrombosis. Journal of the American Medical Association, 292, 1573 1580. (Pubitemid 39314963)
5. Cushman, M., Tsai, A.W., White, R.H., Heckbert, S.R., Rosamond, W.D., Enright, P. Folsom, A.R. (2004b) Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. American Journal of Medicine, 117, 19 25. (Pubitemid 38801482)
6. Folsom, A.R., Wu, K.K., Rosamond, W.D., Sharrett, A.R. Chambless, L.E. (1997) Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation, 96, 1102 1108. (Pubitemid 27344210)
7. Folsom, A.R., Cushman, M., Tsai, M.Y., Aleksic, N., Heckbert, S.R., Boland, L.L., Tsai, A.W., Yanez, N.D. Rosamond, W.D. (2002) A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood, 99, 2720 2725. (Pubitemid 34525357)
8. Folsom, A.R., Golden, S.H., Boland, L.L. Szklo, M. (2005) Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women. European Journal of Epidemiology, 20, 1015 1022. (Pubitemid 41752620)
9. Grady, D., Wenger, N.K., Herrington, D., Khan, S., Furberg, C., Hunninghake, D., Vittinghoff, E. Hulley, S. (2000) Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin replacement study. Annals of Internal Medicine, 132, 689 696. (Pubitemid 30244167)
10. Grodstein, F., Stampfer, M.J., Goldhaber, S.Z., Manson, J.E., Colditz, G.A., Speizer, F.E., Willett, W.C. Hennekens, C.H. (1996) Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet, 348, 983 987. (Pubitemid 26340753)
11. Hernán, M.A., Alonso, A., Logan, R., Grodstein, F., Michels, K.B., Willett, W.C., Manson, J.E. Robins, J.M. (2008) Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology, 19, 766 779.
12. Hoibraaten, E., Qvigstad, E., Andersen, T.O., Mowinckel, M.C. Sandset, P.M. (2001) The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism - results from a randomized, double-blind, clinical trial. Thrombosis and Haemostasis, 85, 775 781. (Pubitemid 32421807)
13. Oger, E., Alhenc-Gelas, M., Lacut, K., Blouch, M.T., Roudaut, N., Kerlan, V., Collet, M., Abgrall, J.F., Aiach, M., Scarabin, P.Y. Mottier, D. (2003) Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 1671 1676. (Pubitemid 37108215)
14. Ohira, T., Cushman, M., Tsai, M.Y., Zhang, Y., Heckbert, S.R., Zakai, N.A., Rosamond, W.D. Folsom, A.R. (2007) ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). Journal of Thrombosis and Haemostasis, 5, 1455 1461. (Pubitemid 46965375)
15. Samama, M.M. (2000) An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Archives of Internal Medicine, 160, 3415 3420.
16. Simon, T., Beau Yon de Jonage-Canonico, M., Oger, E., Wahl, D., Conard, J., Meyer, G., Emmerich, J., Barrellier, M.T., Guiraud, A. Scarabin, P.Y. (2006) Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism. Journal of Thrombosis and Haemostasis, 4, 71 76.
17. Szklo, M., Cerhan, J., Diez-Roux, A.V., Chambless, L., Cooper, L., Folsom, A.R., Fried, L.P., Knopman, D. Nieto, F.J. (1996) Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Epidemiology, 144, 1048 1057. (Pubitemid 26404811)
18. Tsai, A.W., Cushman, M., Rosamond, W.D., Heckbert, S.R., Polak, J.F. Folsom, A.R. (2002a) Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Archives of Internal Medicine, 162, 1182 1189. (Pubitemid 34522408)
19. Tsai, A.W., Cushman, M., Rosamond, W.D., Heckbert, S.R., Tracy, R.P., Aleksic, N. Folsom, A.R. (2002b) Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). American Journal of Medicine, 113, 636 642. (Pubitemid 36015799)
20. White, R.H., Zhou, H., Murin, S. Harvey, D. (2005) Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thrombosis and Haemostasis, 93, 298 305. (Pubitemid 40253735)
21. Wilcosky, T.C. Chambless, L.E. (1985) A comparison of direct adjustment and regression adjustment of epidemiologic measures. Journal of Chronic Diseases, 38, 849 856.
22. Yamagishi, K., Cushman, M., Heckbert, S.R., Tsai, M.Y. Folsom, A.R. (2009) Lack of association of soluble endothelial protein C receptor and PROCR 6936A/G polymorphism with the risk of venous thromboembolism in a prospective study. British Journal of Haematology, 145, 221 226.